241 related articles for article (PubMed ID: 11602647)
21. IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.
Oh S; Perera LP; Burke DS; Waldmann TA; Berzofsky JA
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15154-9. PubMed ID: 15477598
[TBL] [Abstract][Full Text] [Related]
22. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.
Stoklasek TA; Schluns KS; Lefrançois L
J Immunol; 2006 Nov; 177(9):6072-80. PubMed ID: 17056533
[TBL] [Abstract][Full Text] [Related]
23. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells.
Sandau MM; Schluns KS; Lefrancois L; Jameson SC
J Immunol; 2004 Dec; 173(11):6537-41. PubMed ID: 15557143
[TBL] [Abstract][Full Text] [Related]
24. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.
Kawamura T; Koka R; Ma A; Kumar V
J Immunol; 2003 Nov; 171(10):5085-90. PubMed ID: 14607906
[TBL] [Abstract][Full Text] [Related]
25. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
26. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
27. Homeostasis of IL-15 dependent lymphocyte subsets in the liver.
Cepero-Donates Y; Rakotoarivelo V; Mayhue M; Ma A; Chen YG; Ramanathan S
Cytokine; 2016 Jun; 82():95-101. PubMed ID: 26778709
[TBL] [Abstract][Full Text] [Related]
28. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
[TBL] [Abstract][Full Text] [Related]
29. Complement-activated interferon-γ-primed human endothelium transpresents interleukin-15 to CD8+ T cells.
Xie CB; Jiang B; Qin L; Tellides G; Kirkiles-Smith NC; Jane-Wit D; Pober JS
J Clin Invest; 2020 Jul; 130(7):3437-3452. PubMed ID: 32191642
[TBL] [Abstract][Full Text] [Related]
30. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential.
Davey GM; Starr R; Cornish AL; Burghardt JT; Alexander WS; Carbone FR; Surh CD; Heath WR
J Exp Med; 2005 Oct; 202(8):1099-108. PubMed ID: 16216888
[TBL] [Abstract][Full Text] [Related]
31. CD8(+) T cells sabotage their own memory potential through IFN-γ-dependent modification of the IL-12/IL-15 receptor α axis on dendritic cells.
Kohlhapp FJ; Zloza A; O'Sullivan JA; Moore TV; Lacek AT; Jagoda MC; McCracken J; Cole DJ; Guevara-Patiño JA
J Immunol; 2012 Apr; 188(8):3639-47. PubMed ID: 22430740
[TBL] [Abstract][Full Text] [Related]
32. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses.
Rückert R; Brandt K; Bulanova E; Mirghomizadeh F; Paus R; Bulfone-Paus S
Eur J Immunol; 2003 Dec; 33(12):3493-503. PubMed ID: 14635060
[TBL] [Abstract][Full Text] [Related]
34. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells.
Zecher D; Li Q; Oberbarnscheidt MH; Demetris AJ; Shlomchik WD; Rothstein DM; Lakkis FG
J Immunol; 2010 Jun; 184(12):6649-57. PubMed ID: 20483732
[TBL] [Abstract][Full Text] [Related]
35. TRAF2 regulates peripheral CD8(+) T-cell and NKT-cell homeostasis by modulating sensitivity to IL-15.
Villanueva JE; Malle EK; Gardam S; Silveira PA; Zammit NW; Walters SN; Brink R; Grey ST
Eur J Immunol; 2015 Jun; 45(6):1820-31. PubMed ID: 25931426
[TBL] [Abstract][Full Text] [Related]
36. IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells.
Yu P; Bamford RN; Waldmann TA
Eur J Immunol; 2014 Nov; 44(11):3330-41. PubMed ID: 25142300
[TBL] [Abstract][Full Text] [Related]
37. The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells.
Sato N; Patel HJ; Waldmann TA; Tagaya Y
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):588-93. PubMed ID: 17202253
[TBL] [Abstract][Full Text] [Related]
38. Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activation.
Teague RM; Tempero RM; Thomas S; Murali-Krishna K; Nelson BH
J Immunol; 2004 Sep; 173(5):3131-9. PubMed ID: 15322173
[TBL] [Abstract][Full Text] [Related]
39. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.
Rubinstein MP; Kovar M; Purton JF; Cho JH; Boyman O; Surh CD; Sprent J
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9166-71. PubMed ID: 16757567
[TBL] [Abstract][Full Text] [Related]
40. The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development.
Castro I; Yu A; Dee MJ; Malek TR
J Immunol; 2011 Nov; 187(10):5170-82. PubMed ID: 21984699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
